Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Total Current Liabilities: 2014-2025

Historic Total Current Liabilities for ImmunityBio (IBRX) over the last 11 years, with Sep 2025 value amounting to $57.1 million.

  • ImmunityBio's Total Current Liabilities fell 6.28% to $57.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.1 million, marking a year-over-year decrease of 6.28%. This contributed to the annual value of $54.9 million for FY2024, which is 5.73% down from last year.
  • According to the latest figures from Q3 2025, ImmunityBio's Total Current Liabilities is $57.1 million, which was up 12.81% from $50.6 million recorded in Q2 2025.
  • ImmunityBio's Total Current Liabilities' 5-year high stood at $613.5 million during Q2 2023, with a 5-year trough of $49.2 million in Q1 2025.
  • In the last 3 years, ImmunityBio's Total Current Liabilities had a median value of $58.3 million in 2023 and averaged $156.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 460.52% in 2021, then slumped by 90.48% in 2024.
  • ImmunityBio's Total Current Liabilities (Quarterly) stood at $369.0 million in 2021, then soared by 35.74% to $500.9 million in 2022, then slumped by 88.36% to $58.3 million in 2023, then dropped by 5.73% to $54.9 million in 2024, then decreased by 6.28% to $57.1 million in 2025.
  • Its Total Current Liabilities was $57.1 million in Q3 2025, compared to $50.6 million in Q2 2025 and $49.2 million in Q1 2025.